关注
Mahua Dey
Mahua Dey
Neurosurgeon UW Madison
在 neurosurgery.wisc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors
DA Wainwright, AL Chang, M Dey, IV Balyasnikova, CK Kim, A Tobias, ...
Clinical cancer research 20 (20), 5290-5301, 2014
6132014
CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells
AL Chang, J Miska, DA Wainwright, M Dey, CV Rivetta, D Yu, D Kanojia, ...
Cancer research 76 (19), 5671-5682, 2016
5552016
Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
B Auffinger, AL Tobias, Y Han, G Lee, D Guo, M Dey, MS Lesniak, ...
Cell Death & Differentiation 21 (7), 1119-1131, 2014
3802014
Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
AC Filley, M Henriquez, M Dey
Oncotarget 8 (53), 91779, 2017
3562017
Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133+ Glioma Stem Cells to Temozolomide Therapy
IV Ulasov, S Nandi, M Dey, AM Sonabend, MS Lesniak
Molecular medicine 17, 103-112, 2011
2402011
External ventricular drainage for intraventricular hemorrhage
M Dey, J Jaffe, A Stadnik, IA Awad
Current neurology and neuroscience reports 12, 24-33, 2012
1742012
The Evolving Role of CD8+CD28 Immunosenescent T Cells in Cancer Immunology
WX Huff, JH Kwon, M Henriquez, K Fetcko, M Dey
International journal of molecular sciences 20 (11), 2810, 2019
1562019
Plasmacytoid dendritic cell in immunity and cancer
D Mitchell, S Chintala, M Dey
Journal of neuroimmunology 322, 63-73, 2018
1502018
Immune system, friend or foe of oncolytic virotherapy?
AC Filley, M Dey
Frontiers in oncology 7, 106, 2017
1422017
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study
AB Heimberger, W Sun, SF Hussain, M Dey, L Crutcher, K Aldape, ...
Neuro-oncology 10 (1), 98-103, 2008
1402008
Targeting Tregs in malignant brain cancer: overcoming IDO
DA Wainwright, M Dey, A Chang, MS Lesniak
Frontiers in immunology 4, 116, 2013
1362013
Primary central nervous system germ cell tumors: a review and update
K Fetcko, M Dey
Medical research archives 6 (3), 2018
1022018
The role of IDO in brain tumor immunotherapy
L Zhai, KL Lauing, AL Chang, M Dey, J Qian, Y Cheng, MS Lesniak, ...
Journal of neuro-oncology 123, 395-403, 2015
1022015
CART immunotherapy: development, success, and translation to malignant gliomas and other solid tumors
AC Filley, M Henriquez, M Dey
Frontiers in oncology 8, 453, 2018
952018
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated …
M Dey, A Stadnik, F Riad, L Zhang, N McBee, C Kase, JR Carhuapoma, ...
Neurosurgery 76 (3), 291-301, 2015
872015
Recent developments on immunotherapy for brain cancer
DA Wainwright, P Nigam, B Thaci, M Dey, MS Lesniak
Expert opinion on emerging drugs 17 (2), 181-202, 2012
762012
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma
T Hasan, SP Caragher, JM Shireman, CH Park, F Atashi, S Baisiwala, ...
Cell death & disease 10 (4), 292, 2019
732019
Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials
M Dey, A Stadnik, IA Awad
Neurosurgery 74, S142-S150, 2014
722014
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
L Zhai, M Dey, KL Lauing, G Gritsina, R Kaur, RV Lukas, MK Nicholas, ...
Journal of Clinical Neuroscience 22 (12), 1964-1968, 2015
682015
Cancer stem cells: the final frontier for glioma virotherapy
M Dey, IV Ulasov, MA Tyler, AM Sonabend, MS Lesniak
Stem Cell Reviews and Reports 7, 119-129, 2011
632011
系统目前无法执行此操作,请稍后再试。
文章 1–20